[MYGN] YoY Annual Result on 31-Dec-2021 [#FY]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
25-Feb-2022
Financial Year
2021
Quarter
31-Dec-2021 [#FY]
Profit Trend
YoY- 87.84%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 678,400 690,600 557,000 851,100 851,100 772,600 771,400 -2.30%
PBT -140,600 -57,100 -283,700 200 7,700 116,900 42,900 -
Tax -28,600 -29,900 59,900 -4,400 -4,400 -13,900 21,300 -
NP -112,000 -27,200 -223,700 4,600 4,600 131,000 21,800 -
Tax Rate - - - 2,200.00% 57.14% 11.89% -49.65% -
Total Cost 790,400 717,800 780,700 846,500 846,500 641,600 749,600 0.96%
Ratio Analysis
31/12/22 31/12/21 31/12/20 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin -16.51 -3.94 -40.16 0.54 0.54 16.96 2.83 -
Per Share
31/12/22 31/12/21 31/12/20 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
EPS -1.39 -0.35 -2.99 0.06 0.06 1.89 0.32 -
EPS Diluted -1.39 -0.35 -2.99 0.06 0.06 1.82 0.32 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.